Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate

NCT00369304 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: pharmacokinetic (how the body absorbs and eliminates) interaction

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer